SynthesisFrontiers in oncology2026

Survival disparities in HER2-low versus HER2-positive breast cancer: a systematic review of progression-free survival and overall survival.

Widyanti Soewoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.